Incyte INCY
NASDAQ INCY
$127.78 -0.22 (-0.17%)
As of: Sep 4, 2026 · 12:52 PM EDT

Incyte (INCY) Goodwill & Intangibles (2010 - 2026)

Incyte's (INCY) quarterly Goodwill & Intangibles came in at $236.2 million in Q2 2026, down 16.25% YoY from $282.0 million in Q2 2025, and down 2.87% on a QoQ basis from $243.2 million in Q1 2026.

Analysis

Incyte (INCY) Goodwill & Intangibles (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Goodwill & Intangibles data on file, last reported at $236.2 million in Q2 2026.

  • Quarterly Goodwill & Intangibles fell 16.25% year-over-year to $236.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $236.2 million (down 16.25% YoY) and the FY2025 annual result came in at $250.1 million, down 7.15% from the prior year.
  • Goodwill & Intangibles retreated to $236.2 million in Q2 2026, from $243.2 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $301.0 million in Q1 2022 to a low of $236.2 million in Q2 2026.
  • A 5-year average of $275.5 million and a median of $277.4 million in 2023 frame the typical range for Goodwill & Intangibles.
  • Annual changes were most pronounced in 2025 — Goodwill & Intangibles grew 4.79% — and 2026, when it fell 16.25%.
  • Tracing INCY's Goodwill & Intangibles over 5 years: stood at $284.8 million in 2022, then decreased by 1.99% to $279.1 million in 2023, then dropped by 3.49% to $269.4 million in 2024, then slipped by 7.15% to $250.1 million in 2025, then slipped by 5.57% to $236.2 million in 2026.
  • The last three Goodwill & Intangibles figures came in at $236.2 million (Q2 2026), $243.2 million (Q1 2026), and $250.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 Incyte 25.59 Bn 21.05 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 236.20 Mn
Mar 31, 2026 243.16 Mn
Dec 31, 2025 250.13 Mn
Sep 30, 2025 275.01 Mn
Jun 30, 2025 282.01 Mn
Mar 31, 2025 263.20 Mn
Dec 31, 2024 269.40 Mn
Sep 30, 2024 275.59 Mn
Jun 30, 2024 269.13 Mn
Mar 31, 2024 273.43 Mn
Dec 31, 2023 279.14 Mn
Sep 30, 2023 284.84 Mn
Jun 30, 2023 290.55 Mn
Mar 31, 2023 296.25 Mn
Dec 31, 2022 284.81 Mn
Sep 30, 2022 290.20 Mn
Jun 30, 2022 295.58 Mn
Mar 31, 2022 300.96 Mn
Dec 31, 2021 306.35 Mn
Sep 30, 2021 156.14 Mn